Enflame's initial public offering (IPO) attracted overwhelming demand, with orders exceeding the available shares by over 6,000 times, prompting the company to increase the stock allocation for retail investors.
Backed by Tencent, Enflame is part of a group of emerging Chinese AI chipmakers, often referred to as the 'four little dragons.' This group has seen significant stock price increases upon their market entries, with previous IPOs like MetaX and Moore Threads witnessing gains of 700% and 400%, respectively.
The surge in Enflame's stock is indicative of a broader trend where investors are optimistic about the potential for domestic companies to fill the gap left by Nvidia, which currently dominates China's AI accelerator market. According to IDC, Nvidia accounted for nearly 60% of this market in 2025, but U.S. export controls and China's push for tech self-sufficiency are reshaping the landscape.
Goldman Sachs projects that China's semiconductor capital spending could reach $82 billion by 2030, driven by advancements in AI technologies. Enflame reported revenues of 990 million yuan ($147 million) for 2025, an increase from 722 million yuan the previous year, although it has not yet achieved profitability.
The company's plans to utilize IPO proceeds for developing next-generation AI chips highlight its commitment to competing with established international players. The performance of tech hardware stocks, particularly in the semiconductor sector, has been a significant driver of market activity in China recently